Alumis Target Price

Analysts' average 12-month price target for Alumis is $38.

Get informed when a big investor buys or sells

+ Follow

Share Price

$25.55

Average Target Price

$37.80

47.9% upside

5 analysts in the last 4 months

High: $51 | Low: $25

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-05-19	Chardan Capital	$40	56.6% upside
2026-05-15	Morgan StanleyTerence Flynn	$39	52.6% upside
2026-05-15	Wells Fargo	$51	99.6% upside
2026-05-15	GuggenheimYatin Suneja	$34	33.1% upside
2026-05-15	H.C. WainwrightMitchell Kapoor	$25	2.2% downside
2026-03-10	Raymond JamesChristopher Raymond	$46	80% upside
2026-01-21	Chardan Capital	$37	44.8% upside
2026-01-21	Loop Capital MarketsJanani Sundararajan	$37	44.8% upside
2026-01-09	H.C. Wainwright	$40	56.6% upside
2026-01-07	Morgan Stanley	$33	29.2% upside
2026-01-07	GuggenheimYatin Suneja	$32	25.2% upside
2026-01-06	OppenheimerJeff Jones	$50	95.7% upside
2026-01-06	Leerink Partners	$32	25.2% upside
2026-01-06	Wells FargoDerek Archila	$39	52.6% upside
2025-12-18	H.C. WainwrightMitchell Kapoor	$20	21.7% downside
2024-10-30	Robert W. BairdBrian Skorney	$25	2.2% downside
2024-10-17	H.C. WainwrightMitchell Kapoor	$30	17.4% upside
2024-07-23	Cantor FitzgeraldEric Schmidt	$13	49.1% downside

Alumis (ALMS) FAQ

Alumis posts a target price of $38. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $38 for ALMS means covering analysts, on average, see the stock 47.9% upside of $25.55 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for ALMS's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Alumis's other metric pages and overview cover the third.